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Abstract
Objective: Cardiovascular diseases are associated with age-related hear-
ing impairment. But the affected frequencies and audiometric configura-
tions have rarely been studied simultaneously. This study aimed to assess 
the susceptible frequencies and audiometric configurations in subjects with 
coronary artery disease (CAD) and hypertension (HTN).
Materials and Methods: From August 2007 to September 2008, the records 
of 908 adult participants who underwent pure tone audiometry (PTA), who 
were older than 50 years of age, and who were in the non-CAD, non-HTN group 
or who had CAD and/or HTN were collected. The associations of CAD or HTN 
with average PTA level at low (0.25 and 0.5 kHz), middle (1 and 2 kHz), and 
high (4 and 8 kHz) frequencies and audiometric configurations were analyzed.
Results: The presence of CAD, HTN, or both was associated with poor hearing 
thresholds at all frequencies before adjusting for age and sex. Using multi-
variate linear regression analysis, CAD or HTN alone did not show a signifi-
cant association with PTA; but comorbid CAD and HTN showed a significant 
positive association with PTA, especially at the middle and high frequencies. 
“Mild sloping” was the most common audiogram pattern in the non-CAD, 
non-HTN group and in those with both CAD and HTN, and the audiometric 
configurations were not significantly different between the two groups.
Conclusion: Comorbid CAD and HTN had a negative impact on hearing 
function, especially at the middle to high frequencies. However, the effect 
of cardiovascular disease on hearing was not strong enough to change 
the audiogram patterns. [Tzu Chi Med J 2010;22(3):141–145]
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1. Introduction
Cardiovascular disease (CVD) and age-related hear-
ing impairment (ARHI) are very common and closely 
related in elderly individuals [1,2]. Previous reports 
have shown that ARHI is associated with myocardial 
infarction (MI) in women [3], and low-frequency hearing 
loss is associated with an advanced stage of CVD [4]. 
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Retinopathy, a sign of retinal microvascular damage, is 
also associated with hearing impairment in women, 
particularly with low-frequency loss [5]. How ever, hy-
pertension (HTN) is associated with hearing loss in the 
low and middle frequencies in elderly women [6,7], 
and at 1 kHz (middle frequency) only [8]. Therefore, it 
is generally accepted that CVD is associated with hear-
ing impairment, but the detailed relationship between 
the affected frequencies and the severity of CVD re-
mains a matter of debate. It seems that patients with 
mild forms of CVD, such as HTN, have poorer hearing 
in the low to middle frequencies; whereas those with 
advanced CVD, such as MI, or retinopathy, show hear-
ing loss mostly in the low frequencies.
The cochlea is supplied primarily by a spirally ori-
ented internal auditory artery in which the proximal 
portion supplies the basal turn and the distal portion 
supplies the apex. So, it seems reasonable to expect 
that the cochlea apex, which is responsible for low-
frequency hearing, would be more prone to ischemic 
injury. However, this may not be completely true be-
cause of the existence of complex anastomoses and 
autoregulation in the cochlea. Also, direct evidence of 
blood flow disturbance in the cochlea is still lacking 
in most cases [9]. Instead, deterioration of the endo-
cochlear potential affected all the turns of the cochlea 
in a model of angiopathy [10]. Thus, it is still reason-
able to hypothesize that CVD at either an early or ad-
vanced stage might also be associated with loss of 
hearing in the middle and high frequencies.
The association between CVD and ARHI has been 
studied extensively. However, the affected frequencies 
and audiometric configurations have never been ana-
lyzed simultaneously, especially in patients with cor-
onary artery disease (CAD) and HTN. We hypothesized 
that the presence of both CAD and HTN as comorbidi-
ties might be associated with hearing loss not only at 
the low frequencies, but also at the middle or high fre-
quencies. In addition, comorbid CAD and HTN might 
result in specific audiometric configurations. In this 
study, we determined the frequencies of hearing loss 
and audiometric patterns among patients with CAD, 
HTN, or both, and non-CAD, non-HTN individuals.
2. Materials and methods
2.1. Patients
From August 2007 to September 2008, the records of 
908 adult patients who were older than 50 years of 
age and who received routine pure tone audiometric 
(PTA) examinations were collected from the Depart-
ment of Otolaryngology, Buddhist Dalin Tzu Chi General 
Hospital. The institutional review board of Buddhist 
Dalin Tzu Chi General Hospital approved the study 
protocols.
2.2. Inclusion criteria
The inclusion criteria were age > 50 years and normal 
hearing or symmetric sensorineural hearing loss as 
determined by an audiogram (defined as 15 dB or 
less asymmetry at two or fewer frequencies).
2.3. Exclusion criteria
The exclusion criteria were cognitive dysfunction, preg-
nancy, hormone replacement therapy, and a history of 
any of the following: external or middle ear disease, 
conductive hearing loss and a 4-kHz dip on audiogra-
phy, acoustic trauma, exposure to high environmental 
noise or ototoxic drugs, any neurologic or psychiatric 
disease, brain tumor or vestibular schwannoma, MI, 
stroke, claudication, diabetes mellitus, chronic hep-
atitis, liver cirrhosis, chronic renal failure, cancer, 
radiation exposure, heavy smoking, and alcoholism 
or substance abuse. Patients who received coronary 
artery bypass grafting or peripheral artery bypass 
surgery were considered to have severe CVD and 
were excluded as well.
2.4. Definitions of CAD and HTN
CAD was defined as a history of angina pectoris or con-
firmed by exercise electrocardiography (early-onset 
angina, ST-segment depression ≥ 2 mm, ST-segment 
elevation, failure to increase systolic blood pressure 
or a sustained decrease in blood pressure after an 
appropriate rise during exercise, and low exercise tol-
erance) [11] or positive treadmill exercise test, or pos-
itive coronary angiography or positive MI study. HTN 
was defined as a systolic blood pressure ≥ 140 mmHg 
and/or a diastolic blood pressure ≥ 90 mmHg [12].
The participants were divided into four groups: non-
CAD, non-HTN group; patients with CAD; patients with 
HTN; and patients with both CAD and HTN. All patients 
with CAD and/or HTN were treated regularly in the 
outpatient department of the Department of Cardiol-
ogy of our hospital. The non-CAD, non-HTN group was 
selected from the study population and met all of the 
inclusion and exclusion criteria but was free of CAD, 
HTN, and other systemic diseases.
2.5. Hearing levels
Six frequencies were tested on routine PTA. An aver-
age threshold of 250 Hz and 500 Hz in both ears was 
defined as the average pure tone hearing level at low 
frequencies (PTA-low); that of 1 kHz and 2 kHz in both 
ears was defined as the average pure tone hearing 
level at middle frequencies (PTA-mid); and that of 4 kHz 
 TZU CHI MED J  September 2010  Vol 22  No 3 143
and 8 kHz in both ears was defined as the average pure 
tone hearing level at high frequencies (PTA-high). 
In addition, hearing impairment was defined as a 
PTA ≥ 20 decibel hearing level (dB HL).
2.6. Audiometric configurations
We initially classified the audiometric configurations 
of hearing impairment into six types according to the 
following patterns: flat, mild sloping, moderate slop-
ing, abrupt middle-tone loss, abrupt high-tone loss, 
and reverse sloping. These six audiometric configu-
rations were defined as follows: flat, violation of the 
hearing threshold at all frequencies was within 10 dB 
HL; mild sloping, the average of the middle two fre-
quencies (1 and 2 kHz) was greater than that of the 
lower two frequencies (250 and 500 Hz) and smaller 
than that of the higher two frequencies (4 and 8 kHz) 
within 10–20 dB HL; moderate sloping, the average 
of the middle two frequencies (1 and 2 kHz) was 
greater than that of the lower two frequencies (250 
and 500 Hz) and smaller than that of the higher two 
frequencies (4 and 8 kHz) within 20–30 dB HL; abrupt 
middle-tone loss, the average of the middle two fre-
quencies was 30 dB HL or greater than that of the 
lower two frequencies, but the difference between the 
average of the middle two and higher two frequencies 
was within 10 dB HL; abrupt high-tone loss, the aver-
age of the higher two frequencies was 30 dB HL or 
greater than that of the middle two frequencies, but 
the difference between the average of the lower two 
and middle two frequencies was within 10 dB HL; and 
reverse sloping, the average of the lower two frequen-
cies was 10 dB HL or greater than that of the middle 
two frequencies [2].
We found only four types of audiometric configu-
rations (there was no abrupt high-tone loss or reverse 
sloping) in the individuals in this study.
2.7. Statistical analysis
The data are presented as mean ± standard deviation, 
unless otherwise indicated. ANOVA or the χ2 test was 
used to test the differences in variables between 
groups. A multivariate linear regression model using 
the least squares approach was performed to test the 
association of age, sex and diseases with PTA-low, 
PTA-mid and PTA-high. The distribution of audiometric 
configurations in the non-CAD, non-HTN group and 
groups with CAD and/or HTN was analyzed by Fisher’s 
exact probability test. A p value < 0.05 was consid-
ered to be statistically significant. All analyses were 
performed using STATA version 10.0 (StataCorp LP, 
College Station, TX, USA).
3. Results
There were 605 participants in the non-CAD, non-HTN 
group, 42 patients in the CAD group, 191 in the HTN 
group, and 70 in the CAD + HTN group. Mean age was 
62.6 ± 9.02 years (range, 50–93 years); mean age and 
female-to-male ratio were not significantly different 
among groups (Table 1).
The PTAs in the four groups without adjustment for 
age and sex are shown in Table 2. The PTA-low, PTA-
mid and PTA-high were all slightly higher in the HTN 
group and obviously higher in the group with both CAD 
and HTN compared to the non-CAD, non-HTN group 
(p < 0.0001, ANOVA).
Multivariate linear regression analyses for PTA-low, 
PTA-mid and PTA-high by age, sex, and disease are 
shown in Table 3. PTAs were significantly affected by 
age and sex. The presence of both CAD and HTN, but 
not CAD alone or HTN alone, had a significant positive 
association with PTA-mid (β ± SE = 6.31 ± 2.247, p = 
0.005) and PTA-high (β ± SE = 7.80 ± 2.612, p = 0.003). 
But the positive association of both CAD and HTN as 
comorbidities with PTA-low showed only borderline 
significance (β ± SE = 4.07 ± 2.142, p = 0.058).
Table 1 — Age and sex in different disease entities
 n (%) Sex* (F/M), n Age*†
All patients 908 (100) 536/372 62.6 ± 9.02 (50–93)
   CAD only 42 (4.6) 27/15 64.7 ± 8.04 (50–81)
   HTN only 191 (21.0) 104/87 65.1 ± 9.07 (50–89)
   CAD + HTN 70 (7.7) 39/31 69.5 ± 10.07 (50–93)
   Non-CAD,  605 (66.6) 336/239 60.9 ± 8.35 (50–91)
  non-HTN
*Sex and age distribution were not significantly different among 
groups (p = 0.393 for sex, χ2 test; p = 0.097 for age, ANOVA); †data 
presented as mean ± standard deviation (range). CAD = coronary 
artery disease; HTN = hypertension.
Table 2 — Pure tone audiometry (dB HL)*
 Non-CAD, non-HTN CAD only HTN only CAD + HTN p†
PTA-low 23.1 ± 17.28 28.0 ± 20.87 28.0 ± 20.64† 36.2 ± 23.82† < 0.0001
PTA-mid 25.0 ± 18.62 29.4 ± 22.37 31.8 ± 23.37† 41.9 ± 25.47† < 0.0001
PTA-high 38.6 ± 25.03 44.5 ± 25.26 48.1 ± 26.02† 60.1 ± 27.05† < 0.0001
*Data presented as mean ± standard deviation; †ANOVA. CAD = coronary artery disease; HTN = hypertension; PTA = pure tone audiometry.
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In the subgroup analysis by sex, PTA-low was not 
significantly affected by the presence of CAD alone, 
HTN alone, or both in either sex (β ± SE = 3.71 ± 2.562, 
p = 0.149 for women; β ± SE = 4.82 ± 3.643, p = 0.187 for 
men) (data not shown). PTA-mid was significantly af-
fected by the presence of both CAD and HTN as co-
morbidities in women (β ± SE = 6.75 ± 2.793, p = 0.016), 
but the effect was of borderline significance in men 
(β ± SE = 6.10 ± 3.674, p = 0.098) (data not shown). The 
presence of both CAD and HTN as comorbidities was 
significantly associated with elevated PTA-high in 
women only (β ± SE = 8.61 ± 3.321, p = 0.010), but not in 
men (β ± SE = 6.93 ± 4.208, p = 0.100) (data not shown).
There were no abrupt high-tone loss or reverse slop-
ing patterns among the audiometric configurations 
in this study. “Mild sloping” was the most common au-
diometric pattern in the non-CAD, non-HTN (47.3%) 
group and in the CAD + HTN group (35.7%) (Table 4). 
The distribution of audiometric patterns was not sig-
nificantly different between the two groups (p = 0.086, 
Fisher’s exact probability test), although the “abrupt 
middle-tone loss” pattern was slightly more prevalent 
in the CAD + HTN group. The same results were ob-
tained in a subgroup analysis by sex (data not shown).
4. Discussion
This cross-sectional study provides new insight into the 
characteristics of hearing impairment in patients with 
both CAD and HTN. We found that the presence of CAD 
or HTN alone was not significantly associated with hear-
ing loss in elderly individuals, but the presence of both 
of these two diseases was. However, we could not find 
an audiometric configuration that was specific to the 
presence of CAD and HTN as comorbidities.
Previous studies showed that CVD is associated 
with ARHI, especially in older women [3–5,7,8]. It has 
been shown that the incidence of heart disease among 
women rapidly approaches that in men [13], and 
women lose the protective effect of estrogen on hear-
ing after menopause [14–16]. Therefore, it is reason-
able to conclude that the hearing of women could be 
more obviously affected by CVD. Our results support 
these findings [3–5,7,8].
CVD has been reported to be associated with low-
frequency [6,8] and middle-frequency hearing loss 
[5,8]. From the pathophysiological perspective, it is 
reasonable to expect that the cochlea apex, which is 
responsible for low-frequency hearing, would be more 
prone to ischemic injury. But angiopathy could also 
lead to reduction of the endocochlear potential [10], 
which could affect all turns of the cochlea. Thus, the 
observation that CVD is associated with middle- and 
high-frequency loss is also reasonable. However, it 
is still unknown which mechanisms are dominant or 
which frequencies would be affected first and which 
later as CVD deteriorates.
In this study, we excluded patients with MI, stroke, 
coronary artery bypass graft, peripheral artery bypass 
surgery, and other systemic diseases. We found that 
hearing loss was significant in the middle and high fre-
quencies among women who had both CAD and HTN 
as comorbidities and who were not receiving hormone 
replacement therapy. In contrast, the audiometric con-
figuration analysis did not support our findings at the 
affected frequencies. In fact, the findings of the af-
fected frequencies could not be directly applied to the 
Table 3 — Multivariate linear regression analysis for PTA-low, PTA-mid and PTA-high by age, sex and comorbidity*
 PTA-low PTA-mid PTA-high
Age 1.04 ± 0.064 (< 0.001) 1.207 ± 0.067 (< 0.001) 1.50 ± 0.078 (< 0.001)
Sex† 1.89 ± 1.120 (0.091) 5.67 ± 1.174 (< 0.001) 14.71 ± 1.365 (< 0.001)
Non-CAD, non-HTN‡ – – –
CAD only 0.97 ± 2.631 (0.712) 0.06 ± 2.760 (0.983) 0.60 ± 3.208 (0.851)
HTN only 0.52 ± 1.388 (0.707) 1.50 ± 1.456 (0.303) 2.34 ± 1.692 (0.166)
CAD + HTN 4.07 ± 2.142 (0.058) 6.31 ± 2.247 (0.005) 7.80 ± 2.612 (0.003)
Adjusted R2 0.2625 0.3286 0.4146
*Data presented as β ± standard error (p); †male versus female; ‡data for the CAD only, HTN only and CAD + HTN groups are shown compared to 
the non-CAD, non-HTN group with statistical adjustment of the other variables. β = coefficient; PTA = pure tone audiometry; CAD = coronary artery 
disease; HTN = hypertension.
Table 4 — Audiometric configurations in the non-CAD, non-HTN and CAD + HTN groups*†
 Pattern
 Mild sloping Moderate sloping Abrupt middle tone loss Flat 
Total
Non-CAD, non-HTN 286 (47.3) 138 (22.8) 130 (21.5) 51 (8.4) 605 (100)
CAD + HTN  25 (35.7)  17 (24.3)  24 (34.3)  4 (5.7)  70 (100)
*Data presented as n (%); †difference between groups was insignificant (p = 0.086, Fisher’s exact probability test).
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audiometric configurations. The audiogram patterns 
of most participants with both CAD and HTN were still 
of the “mild sloping” type and were not significantly 
different from those of the non-CAD, non-HTN pa-
tients, although some frequencies worsened because 
of CVD status. In other words, we suggest that the ef-
fect of CVD on hearing is not strong enough to change 
the audiogram pattern.
The results of this cross-sectional study by chart 
review might be weakened by information bias and 
classification bias. Therefore, a large-scale prospective 
cohort study should be conducted to classify the ac-
tual susceptible frequencies in both early-stage and 
advanced-stage CVD. Also, audiogram patterns should 
be classified into more categories and be linked to 
specific diseases.
The hearing thresholds were not affected by CAD 
or HTN alone, but hearing at middle to high frequen-
cies was negatively associated with comorbid CAD and 
HTN in elderly women. However, the effect of CVD on 
hearing was not strong enough to change the audio-
gram patterns.
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